Heart Failure Pharmacology
Sort by:
Heart Failure 2021
Q&A: Management of Hyperkalemia and Heart Failure
FEATURING
Joao Pedro Ferreira
- 164 views
- October 15, 2021
- 2
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
FEATURING
Anuradha Lala-Trindade
- 1,243 views
- December 15, 2021
- 17
The Texas Heart Institute
Update of Diabetes Treatment: Overview of Current Trials and ADA Practice Recommendations
FEATURING
David Aguilar
- 776 views
- November 11, 2021
- 6
American Heart & Vascular Institute
Q&A: Understanding SGLT-2 Inhibitors in the CardioNephroEndo Space
- 503 views
- September 9, 2021
American Heart & Vascular Institute
Heart Failure With Reduced Ejection Fraction: New Therapies on the Horizon
FEATURING
Nasrien Ibrahim
- 1,163 views
- September 16, 2021
- 9
Georgia Heart Institute
Updates on the Cardiometabolic Therapies
FEATURING
Jaime Burkle
- 762 views
- June 21, 2022
- 7
Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension
Pulmonary Hypertension with HFpEF
FEATURING
Sanjiv J. Shah
- 666 views
- October 15, 2018
- 4
Mount Sinai Advanced Heart Symposium 2016
Eliminating Disparities in Heart Failure
FEATURING
Clyde Yancy
- 826 views
- February 15, 2017
- 2
Scripps Health
Heart Failure Therapies You’ve Never Heard Of
FEATURING
Rajeev Mohan
- 980 views
- May 26, 2022
- 8
Cardiovascular Disease Management - 5th Annual Symposium
What’s New in Heart Failure Treatment? What Role Do the New Agents Have?
FEATURING
Uri Elkayam
- 1,132 views
- December 27, 2017
- 3
Heart Failure 2021: An Update on Therapy
Use of Diuretics in Patients With Volume Overload: What to Do When You See Diuretic Resistance?
FEATURING
Jeffrey Testani
- 644 views
- March 30, 2021
- 11
16th Annual Heart Failure Holiday Symposium
New Treatment Approaches to HFrEF: When to Use SGLT2, Vericiguat, Omecamtiv Mecarbil and IV Iron?
FEATURING
Mark Drazner
- 1,116 views
- February 18, 2021
- 12
Keck School of Medicine of USC
Takotsubo Syndrome: What Diagnostic Criteria Are Available? Which Drugs to Use and Which Should Be Avoided?
FEATURING
Helga Van Herle
- 533 views
- February 11, 2021
- 8
Yale School of Medicine
ACC 21 Highlights: Angiotensin Receptor Neprilysin Inhibition Following Acute MI (PARADISE-MI) Trial
FEATURING
Rohan Khera
- 340 views
- June 14, 2021
- 1
The North American Thrombosis Forum (NATF)
AHA 2020 Trial Takeaways: Should Rivaroxaban Be Used in Patients with Bioprosthetic Valves? Can Vitamin D, Omega-3 Supplementation and Early Ablation Decrease the Incidence of Afib and Other CV Events?
FEATURING
Christian Cruff
- 623 views
- December 17, 2020
- 4
CSI Education
Interatrial Shunting: Open Discussion
FEATURING
Nikolaus Haas,
Roman Pfister,
Shakeel Qureshi,
Kong Xiangqing,
Daniel Burkhoff,
William Abraham,
Gregg Stone,
Horst Sievert
- 261 views
- August 18, 2020
Keck School of Medicine of USC
Newer Therapies in Management of Chronic Heart Failure: Roles of SGLT2 Inhibitors and Vericiguat
FEATURING
Kruti Pandya
- 290 views
- December 28, 2020